financetom
Business
financetom
/
Business
/
Cryptocurrency exchange Kraken says US SEC will dismiss lawsuit
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cryptocurrency exchange Kraken says US SEC will dismiss lawsuit
Mar 3, 2025 8:11 AM

NEW YORK (Reuters) -Cryptocurrency exchange Kraken said on Monday that the U.S. Securities and Exchange Commission had agreed in principle to dismiss a civil lawsuit accusing it of illegally operating as an unregistered securities exchange.

In a statement on its blog, Kraken said the dismissal is with prejudice, with no admission of wrongdoing, no penalties paid and no changes to its business.

The SEC declined to comment.

Kraken was sued in November 2023, as part of former SEC Chair Gary Gensler's push to bring cryptocurrency under his agency's purview.

But the SEC has changed its approach towards cryptocurrency since U.S. President Donald Trump began his second term. He has nominated Paul Atkins, a Washington lawyer seen as supportive of digital assets, to become SEC chair.

Kraken called the SEC decision to end the lawsuit "a turning point" for cryptocurrency in the United States, saying "it ends a wasteful, politically motivated campaign" that stifled innovation and investment.

"We appreciate the new leadership both at the White House and the Commission that led to this change," it added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Shoals Technologies Appeals International Trade Commission Decision in Patent Infringement Suit With Voltage
Shoals Technologies Appeals International Trade Commission Decision in Patent Infringement Suit With Voltage
Feb 12, 2025
04:43 AM EST, 02/12/2025 (MT Newswires) -- Shoals Technologies Group ( SHLS ) said late Tuesday it has filed an appeal with the US Court of Appeals for the Federal Circuit challenging the International Trade Commission's reversal of an earlier ruling that Voltage's LYNX trunk bus products infringed Shoals' '153 patent. The appeal seeks a de novo review, asking the...
Update: Upstart Q4 Tops Estimates; FY25 Revenue Guidance Above Consensus; Shares Soar Premarket
Update: Upstart Q4 Tops Estimates; FY25 Revenue Guidance Above Consensus; Shares Soar Premarket
Feb 12, 2025
04:49 AM EST, 02/12/2025 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Upstart Holdings ( UPST ) shares were up more than 26% in premarket activity Wednesday after the company said overnight that it swung into the black in Q4 as sales surged. Its full-year revenue guidance also beat market expectations. The company...
SpringWorks Therapeutics Says Gomekli Receives FDA Approval for Genetic Disorder
SpringWorks Therapeutics Says Gomekli Receives FDA Approval for Genetic Disorder
Feb 12, 2025
04:56 AM EST, 02/12/2025 (MT Newswires) -- SpringWorks Therapeutics ( SWTX ) said late Tuesday the US Food and Drug Administration has approved Gomekli, or mirdametinib, for the treatment of certain patients with neurofibromatosis type 1, a genetic disorder with symptoms including abnormal pigmentation and tumor growth. The approval is based on findings from a phase 2b trial in which...
STAAR Surgical Swings to Loss in Fiscal Q4, Sales Drop; Plans Cost-Cutting; Shares Plunge Premarket
STAAR Surgical Swings to Loss in Fiscal Q4, Sales Drop; Plans Cost-Cutting; Shares Plunge Premarket
Feb 12, 2025
05:21 AM EST, 02/12/2025 (MT Newswires) -- STAAR Surgical ( STAA ) reported a fiscal Q4 loss late Tuesday of $0.69 per diluted share, compared with earnings of $0.16 a year earlier. Analysts polled by FactSet expected a loss of $0.18. Net sales for the quarter that ended Dec. 27 was $49 million, down from $76.3 million a year earlier....
Copyright 2023-2026 - www.financetom.com All Rights Reserved